These re-agents come with 99.7 percent accuracy, the highest level of sensitivity, a shelf-life of 24 months, unique packaging and competitive price-points.
The company has filed India patents for these re-agents which will strengthen the preventive healthcare mechanism for critical diseases.
LordsMed will manufacture these re-agents at its manufacturing facility in Maharashtra and make these re - agents available to pathological labs, hospitals and research institutes through its Pan - India distribution network of over 300 dealers.
LordsMed will use the re-agents in its chain of pathological labs as well.
The company has plans to export the re-agent in key global markets.
LordsMed aims to generate revenue by supplying these reagents Pan India and within SAARC, African and Eastern Europe countries in global markets within couple of years.